JR

Joseph Raker

Executive Vice President, CMC at Immunophotonics, Inc.

Joseph Raker has a comprehensive work experience in the pharmaceutical industry. Joseph started their career at AMRI as a Senior Research Scientist and later became a Senior Manager in Project Management. In this role, they were responsible for overseeing all project management activities and played a key role in developing and implementing site-wide initiatives. In 2012, Joseph joined Kinentia Biosciences as the Director of Consulting and Project Management Services, where they provided their expertise in drug development and commercial manufacturing, specifically in sterile fill/finish and organic/medicinal chemistry. Currently, they serve as the Chief Drug Development Officer at Immunophotonics Inc, a role which they have held since 2014.

Joseph Raker has a Bachelor of Science (BS) degree in Chemistry from Utica University, which they obtained from 1993 to 1997. Joseph then pursued further education at Penn State University, where they earned a Doctor of Philosophy (Ph.D.) in organic chemistry from 1997 to 2002.

Location

St. Louis, United States

Links


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Immunophotonics, Inc.

ImmunoPhotonics develops immunotherapy-based treatments for cancer. A minimally invasive therapeutic cancer vaccine for the treatment of metastatic solid tumors. ImmunoPhotonics has a strategic partnership with Veterinary Cancer Therapeutics, LLC. The company was founded in 2008 and is based in Columbia, Missouri.


Employees

11-50

Links